Introducing Sugammadex Sodium made by Medichem

Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically integrated manufacturer of the product, providing both the API and FDF. Our API plant in Malta offers our customers the competitive advantage of an early launch in countries without patent protection. Medichem´s Sugammadex has been filed globally including in the USA […]

Read More…

Medichem’s R&D and Business Development summit in ESADECREAPOLIS

What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem’s R&D and Business Development summit? On July 9th and 10th, the R&D, Business Development and Project Management departments met to discuss Medichem’s innovative and commercial projects. An ideal opportunity to collaborate, fine-tune details and thereof optimize each project. Learning, collaborating, conveying ideas, working […]

Read More…

USP’s Donor Recognition Program would like to recognize Medichem for its contributions…

  “USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year” Says Ronald T. Piervincenzi, Ph.D. USP Chief Executive Officer. This program recognizes new and modernized monographs that were published in one of USP’s forums or were posted to USP’s website for comment, as well as those reference […]

Read More…